Epcoritamab (Anti-CD20 & CD3)
£349.50
Epcoritamab (Anti-CD20 & CD3) (A4008-1mg)
Product
| Cat # A4008-1mg | Size 1mg |
Price
£349.50
|
Qty
|
Description
Epcoritamab is a bispecific IgG1 antibody that targets CD3 and CD20, exhibiting strong T-cell-mediated cytotoxic activity against CD20+ malignant B cells. It is used in the treatment of adults in relapsed or refractory (R/R) large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma after ≥2 lines of systemic treatment. MW: 145.26 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4008 |
| Target | CD markers |